12/10/2010 15:00:00

Alion Awarded EPA Contract Valued at up to $72 Million to Conduct Research on Human Pollutant Exposures

Alion Science and Technology, an employee-owned technology solutions

company, was awarded a five-year task-order from the Environmental

Protection Agency (EPA), worth a maximum of $72 million, to continue its

work providing research support to assess exposure to atmospheric

pollutants and other materials that have the potential to cause adverse

human health effects.

Alion supports EPA’s Office of Research and Development by assisting

with the conduct of research that characterizes human pollutant

exposures across a broad spectrum. Our subcontractor RTI International

is a key partner in this effort. Results will be applied to practical

efforts related to air quality measurement, pollution control and

homeland security.

“We support the continuing improvement in our understanding of how

people become exposed to air pollutants,” explained Chris Amos, Alion

Senior Vice President and Manager of the company’s Technology Solutions

Group. “Alion has a long history with EPA, dating back to 1973, in

conducting atmospheric sciences and environmental methods development

research, with an increased emphasis on studying human exposure.

Ultimately, the research we are conducting now may help prevent negative

health effects from pollutants.”

Under the contract, Alion will develop and support human exposure models

and support research in aerosol and human exposure studies. Pollutants

and other compounds will be sampled and analyzed in air, water, food,

dust, soil and biological media, and tracked through inhalation, dermal

exposure and ingestion.

Other subcontractors on the five-year contract include The McConnell

Group and Alpha-Gamma Technologies.

The mission of EPA is to protect human health and the environment. EPA's

purpose is to ensure that all Americans are protected from significant

risks to human health and the environment where they live, learn and

work.

About Alion Science and Technology

Alion Science and Technology is an employee-owned technology solutions

company delivering technical expertise and operational support to the

Department of Defense, civilian government agencies and commercial

customers. Building on almost 75 years of R&D and engineering expertise,

Alion brings innovation and insight to multiple business areas: naval

architecture & marine engineering; defense operations; modeling &

simulation; technology integration; information technology & wireless

communications; and energy and environmental sciences. Based in McLean,

Virginia, Alion employee-owners are located at major offices, customer

sites and laboratories worldwide. For more information, call

877.771.6252 or visit Alion online at www.alionscience.com.

This press release contains information about management’s view of

Alion’s future expectations, plans and prospects that constitute

forward-looking statements for purposes of the safe harbor provisions

under The Private Securities Litigation Reform Act of 1995. Actual

results may differ materially from those indicated by these

forward-looking statements as a result of a variety of risk factors and

uncertainties discussed in documents periodically filed by Alion with

the SEC.

Due to such uncertainties and risks, readers are

cautioned not to place undue reliance on such forward-looking

statements, which speak only as of the date hereof.

Alion Science and Technology

Peter J. Jacobs, 703-269-3473

pjacobs@alionscience.com

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Feb
NOVO-B
Når ens hustru har lidt voldsomt under diabetes  og dens bivirkninger tiltagende gennem 25 år, så er..
34
19 Feb
 
Jeg tager hatten for dit velbegrunede og fyldestgørende indlæg til debatten. Det kunne mange lære af..
32
21 Feb
GEN
Det er altid rart at møde et ungt menneske, der har potentiale til at blive klogere.
26
23 Feb
ZEAL
Jeg har tildigere her på EI rapporteret at Soliqua ville blive lanceret i Sydkorea. Nu har Sanofi af..
25
21 Feb
GEN
Du bliver da dummere og dummere at høre på 
21
24 Feb
NRDF
  Aktieugen er overstået og desværre, men ikke særligt overraskende, viste det sig igen, at det dans..
15
23 Feb
ZEAL
Sanofi og  har for et par dage siden oplyst på clinicaltrial.gov at de starter studiet «LixiPark» me..
14
23 Feb
GEN
H2 2018 er pakket med nyheder og kliniske data fra daratumumab i solide tumorer er en af de største ..
12
21 Feb
TRMD-A
Mange års erfaring i teknisk analyse berettiger mig til at give dig følgende svar:    Torm viser akt..
12
20 Feb
 
Helt korrekt. Jeg skiftede job i 2007 og har på denne ene pension fra dette tidspunkt indbetalt 648...
12

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Pomerantz Law Firm Announces the Filing of a Class Action against Bellicum Pharmaceuticals, Inc. and Certain Officers – BLCM
2
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MetLife, Inc. of Class Action Lawsuit and Upcoming Deadline – MET
3
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Super Micro Computer, Inc. of Class Action Lawsuit and Upcoming Deadline – SMCI
4
Canada’s Johnston Maintains Lead after Day Three of FLW Tour at Harris Chain of Lakes Presented by Lowrance
5
PRF: Consolidated Unaudited Interim Report of AS PRFoods for 4th quarter and 12 months of 2017

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 February 2018 09:40:28
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20180222.1 - EUROWEB1 - 2018-02-25 10:40:28 - 2018-02-25 09:40:28 - 1000 - Website: OKAY